MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Net loss-$3,630,610 Net loss beforeprovision for income taxes-$3,630,610 Health Care PatientService$1,082,210 Histology Service Fees$250,516 Medical Director Fees$17,461 Department Of DefenseObservational Studies$1,131 Other Revenues$209 Loss from operations-$3,616,976 Total other expense-$13,634 Net revenue$1,351,527 Interest income$10,026 Total operatingexpenses$4,968,503 Interest expense$14,722 Other expense$8,938 Selling, general andadministrative$3,241,602 Direct costs andexpenses$928,636 Research and development$349,707 Clinical development$334,040 Depreciation andamortization$114,518
Income Statement

bioAffinity Technologies, Inc. (BIAF)

bioAffinity Technologies, Inc. (BIAF)

source: myfinsight.com